According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$0.27 Billion. In 2023 the company made a revenue of C$0.50 Billion an increase over the revenue in the year 2022 that were of C$30.16 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | C$0.26 B | -47.92% |
2023 | C$0.50 B | 1574.31% |
2022 | C$30.16 M | |
2021 | N/A |